Tumour microdissemination and survival in metastatic melanoma

Anticancer Research

Volumn 20, Issue 5 B, 2000, Pages 3619-3624

  Schrader, A J ^a   Probst Kepper, M ^a   Grosse, J ^a   Kunter, U ^a   Franzke, A ^a   Sel, S ^a   Atzpodien, E ^a   Buer, J ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

Clinical prognosis; Genetic heterogeneity; Metastatic malignant melanoma; Multiple marker RT PCR; Tumour cell microdissemination

Indexed keywords

MONOPHENOL MONOOXYGENASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; BONE MARROW; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; MONOPHENOL MONOOXYGENASE; NEOPLASM CIRCULATING CELLS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0033635769     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Expression of MAGE genes in primary and metastatic cutaneous melanoma
2. Melonoma-associated antigens as messenger RNA detection markers for melanoma
3. Heterogeneous expression of immunotherapy candidate proteins gp100, MART 1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions
4. Peripheral blood tyrosinase messenger RNA, detection and survival in malignant melanoma
5. Polymerase chain reaction detection of circulating melanocytes as a prognostic marker in patients with melanoma
6. Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: Association with clinical stage and prognosis
7. Polymerase chain reaction detection of melanoma cells in the circulation: Relation to clinical stage, surgical treatment, and recurrence from melanoma
8. Correlation of positive RT- PCR for tyrosinase in peripheral blood of malignant melanoma patients with clinical stage, survival and other risk factors
9. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction
10. Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay
11. Evaluation of tyrosinase mRNA as a tumor marker in the blood of melanoma patients
12. Nonparametric estimation from incomplete observations
13. Current therapy for malignant melanoma
14. Prognostic value of serum analyses of S-100 protein beta in malignant melanoma
15. Lymph node micrometastases of cutaneous melanoma: Increased sensitivity of molecular diagnosis in comparison to immunohistochemistry
16. The detection of melanoma cells in peripheral blood by reverse transcription polymerase chain reaction
17. Detection of circulating melanoma cells by specific amplification of tyrosinase complementary DNA is not a reliable tumor marker in melanoma patients: A clinical two-center study
18. Diagnostic PCR in melanoma, methods and quality assurance
19. Detection of melanoma cells in peripheral blood stem cell harvests of patients with progressive metastatic malignant melanoma
20. Changes in expression of putative antigens encoded by pigment genes in mouse melanomas at different stages of malignant progression